Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
HD17 for Intermediate Stage Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Status
- RECRUITING
- Phase
- N/A
IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Screening for Coronary Artery Disease After Mediastinal Irradiation
- Status
- COMPLETED
- Phase
- NA
A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess AFM13 in Patients With Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE2
Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
- Status
- COMPLETED
- Phase
- PHASE2